⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)

Official Title: The Effects of Chinese Herbal Medicine and Letrozole on Live Birth in Infertile Women With Polycystic Ovary Syndrome:A Double-blind Randomized Controlled Trial

Study ID: NCT01431352

Study Description

Brief Summary: This is a multicenter double-blind randomized controlled trial. A total of 420 anovulatory Chinese women with PCOS will be recruited, and the randomization will be stratified by each participating site. Participants will be randomized into one of the two treatment arms: letrozole and CHMG or letrozole and CHMG placebo. CHMG or its placebo will be taken twice a day for up to six months. Letrozole (2.5 mg daily) was given on days 3-7 of the menstrual cycle after a spontaneous period or withdrawal bleeding, and the dose will be increased to 5.0 mg daily during the last three months for non-pregnant women in both groups.The aim of the present study is to determine the efficacy of combined treatment with letrozole and CHMG on improving live birth rates in infertile Chinese women with PCOS. Our hypothesis is that the combination of letrozole and CHMG is more likely to increase the ovulation rate and decrease the miscarriage rate and result in a higher live birth rate in PCOS women than letrozole alone.

Detailed Description:

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China

Guangzhou Medical School First Affiliated Hospital, Guangzhou, Guangdong, China

Daqing Longnan hospital, Daqing, Heilongjiang, China

Daqing Oilfield General Hospital, Daqing, Heilongjiang, China

First Affliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

Dept Obs & Gyn, First Affiliated Hospital National Key Discipline and Trial Base Heilongjiang University of Chinese Medicine, Herbin, Heilongjiang, China

Mudanjiang maternal and children hospital, Mudanjiang, Heilongjiang, China

2nd Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China

First Affiliated Hospital of Hunan University of Chinese, Changsha, Hunan, China

SuqianMaternal and Child Health Hospital, Suqian, Jiangsu, China

Maternal and Child Health Hospital of Xuzhou, Xuzhou, Jiangsu, China

First Hospital, Jiangxi college of Chinese Medicine, Nanchang, Jiangxi, China

Dalian Maternal and Child Health Hospital, Dalian, Liaoning, China

Shanxi Hospital of Chinese Medicine, Taiyuan, Shanxi, China

First Affiliated Hospital of Tianjin University of Chinese Medicine, Tianjin, Tianjin, China

Second Affiliated Hospital, Tianjin University of Chinese Medicine, Tianjin, Tianjin, China

Zhejiang province hospital of integrated traditional and western medicine, Hangzhou, Zhejiang, China

Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, , China

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: